NCT05250505 - Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

April 30, 2027

Conditions

Hydrocephalus, Normal PressureHydrocephalus

Interventions

DEVICE

eShunt Implant

The eShunt System consists of endovascular delivery componentry and a permanent implant intended to shunt cerebrospinal fluid from the intracranial subarachnoid space to the venous system in adults.

Trial Locations (1)

C1426B

Clínica La Sagrada Familia, Buenos Aires